Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvera

Showing results (541-550 of 579) with videos related to

Pageof 58
Sort By:
Photochemistry and Photobiology|August 14, 2025
Experimental assessment of photodynamic therapy effects on 4NQO-induced rat tongue carcinogenesis: Clinical, morphological, and immunohistochemical analysisLauren Frenzel Schuch, Tuany Rafaeli Schmidt, Daniela Campagnol, et al.
Environmental Monitoring and Assessment|February 22, 2023
Regulation of CO<sub>2</sub> by the sea in areas around Latin America in a context of climate changeV Lutz, M Chidiak, R Frouin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALSJesús A Pérez-Cabello, Lucía Silvera-Carrasco, Jaime M Franco, et al.
Annals of Hepatology|August 11, 2015
Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast MexicoLinda E Muñoz-Espinosa, Maria E Trujillo-Trujillo, Roberto F Martínez-Macías, et al.
Molecular Pharmaceutics|October 30, 2010
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosisMark E Lobatto, Zahi A Fayad, Stephane Silvera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
PNAS Nexus|October 1, 2025
Can reminder emails compel Americans to save? A two-million-person megastudyKatherine L Milkman, Sean F Ellis, Dena M Gromet, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
BMC Infectious Diseases|April 25, 2022
Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infectionErika Reategui Schwarz, Adriana van de Guchte, Amy C Dupper, et al.
Pageof 58

Showing results (541-550 of 579) with videos related to

Sort By:
Pageof 58
Photochemistry and Photobiology|August 14, 2025
Experimental assessment of photodynamic therapy effects on 4NQO-induced rat tongue carcinogenesis: Clinical, morphological, and immunohistochemical analysisLauren Frenzel Schuch, Tuany Rafaeli Schmidt, Daniela Campagnol, et al.
Environmental Monitoring and Assessment|February 22, 2023
Regulation of CO<sub>2</sub> by the sea in areas around Latin America in a context of climate changeV Lutz, M Chidiak, R Frouin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALSJesús A Pérez-Cabello, Lucía Silvera-Carrasco, Jaime M Franco, et al.
Annals of Hepatology|August 11, 2015
Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast MexicoLinda E Muñoz-Espinosa, Maria E Trujillo-Trujillo, Roberto F Martínez-Macías, et al.
Molecular Pharmaceutics|October 30, 2010
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosisMark E Lobatto, Zahi A Fayad, Stephane Silvera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
PNAS Nexus|October 1, 2025
Can reminder emails compel Americans to save? A two-million-person megastudyKatherine L Milkman, Sean F Ellis, Dena M Gromet, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
BMC Infectious Diseases|April 25, 2022
Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infectionErika Reategui Schwarz, Adriana van de Guchte, Amy C Dupper, et al.
Pageof 58